Cargando…
Construction of Nomograms for Predicting Pathological Complete Response and Tumor Shrinkage Size in Breast Cancer
PURPOSE: Pathological complete response (pCR) is the goal of neoadjuvant chemotherapy (NAC) for the HER2-positive and triple-negative subtypes of breast cancer and is related to survival benefit; however, luminal breast cancer is not sensitive to NAC, and the size of tumor shrinkage is a more meanin...
Autores principales: | Yan, Shuai, Wang, Wenjie, Zhu, Bifa, Pan, Xixi, Wu, Xiaoyan, Tao, Weiyang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7489938/ https://www.ncbi.nlm.nih.gov/pubmed/32982426 http://dx.doi.org/10.2147/CMAR.S270687 |
Ejemplares similares
-
Construction and Validation of a Serum Albumin-to-Alkaline Phosphatase Ratio-Based Nomogram for Predicting Pathological Complete Response in Breast Cancer
por: Qu, Fanli, et al.
Publicado: (2021) -
LncRNA DANCR contributes to tumor progression via targetting miR-216a-5p in breast cancer: lncRNA DANCR contributes to tumor progression
por: Tao, Weiyang, et al.
Publicado: (2019) -
Correcting the Shrinkage Effects of Formalin Fixation and Tissue Processing for Renal Tumors: toward Standardization of Pathological Reporting of Tumor Size
por: Tran, Thu, et al.
Publicado: (2015) -
Construction of nomograms for nasopharyngeal carcinoma containing primary tumor size and SEER stage
por: Yang, Guangrong, et al.
Publicado: (2020) -
Systematic Review of Nomograms Used for Predicting Pathological Complete Response in Early Breast Cancer
por: Antonini, Marcelo, et al.
Publicado: (2023)